Hypophrenia
New member
Mylab & Serum Institute launch India’s first nasal influenza vaccine Nasovac S4
Mylab and Serum Institute of India have launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is recommended for individuals above the age of 2. It aims to provide superior protection against influenza and enhance vaccination rates by offering a more comfortable and accessible option. The vaccine is currently available in private markets in India.